References
- Schlom J, Weeks M O. Potential clinical utility of monoclonal antibodies in the management of human carcinomas. Important Advances in Oncology 1985, V T DeVita, S Hellman, S A Rosenberg. J.B. Lippincott Company, Philadelphia 1985; 170–192
- Horan Hand P, Nuti M, Colcher D, Schlom J. Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor associated antigens. Cancer Res 1983; 43: 728–735
- Lottich S C, Johnston W W, Szpak C A, et al. Correlation of the expression of a tumor-associated antigen (TAG-72) in primary and metastatic breast carcinoma lesions. Breast Cancer Research Treatment 1985; 6: 49–56
- Colcher D, Horan Hand P, Nuti M, et al. A spectrum of monoclonal antibodies reactive with mammary tumor cells. Proc Natl Acad Sci USA 1981; 78: 3199–3202
- Johnson V G, Schlom J, Paterson A J, et al. Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res 1986; 46: 850–857
- Stramignoni D, Bowen R, Atkinson B F, et al. Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas. Int J Cancer 1983; 31: 543–552
- Nuti M, Teramoto Y A, Mariani-Costantini R, et al. A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor associated antigen in human mammary carcinoma cell populations. Int J Cancer 1982; 29: 539–545
- Hsu S M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: A comparison between ABC and unlabeled antibody (PA) procedures. J Histochem Cytochem 1981; 29: 577–580
- Schlom J, Personal communication
- Kerbel R S. Implications of immunological heterogeneity of tumors. Nature 1979; 280: 358–360
- Hart I E, Fidler I J. The implications of tumor heterogeneity for studies on the biology and therapy of cancer metastasis. Biochem Biophys Acta 1981; 651: 37–50
- Prehn R T. Analysis of antigenic heterogeneity within individual 3-methylcholanthrene-induced mouse sarcomas. J Natl Cancer Inst 1970; 45: 1039–1045
- Pimm M V, Baldwin R W. Antigenic differences between primary methylcholanthrene-induced rat sarcomas and post-surgical recurrences. Int J Cancer 1977; 20: 37–43
- Miller F R, Heppner G H. Immunologic heterogeneity of tumor cell subpopulations from a single mouse mammary tumor. J Natl Cancer Inst 1979; 63: 1457–1463
- Poste G, Doll J, Fidler I J. Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells. Proc Natl Acad Sci USA 1981; 78: 6226–6230
- Fossati G, Taramelli D, Balsari A, et al. Primary but not metastatic human melanomas expressing DR antigens stimulate autologous lymphocytes. Int J Cancer 1984; 33: 591–597
- Horan Hand P, Colcer D, Salomon D, et al. Influence of spatial configuration of carcinoma cell populations on the expression of a tumor-associated glycoprotein. Cancer Res 1985; 45: 833–840
- Dukes C E, Bussey H JR. The spread of rectal cancer and its effect on prognosis. Br J Cancer 1958; 12: 309–320